Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7-8
|
| pubmed:dateCreated |
1980-7-12
|
| pubmed:abstractText |
Skeletal isotopic exploration is fundamental in patients with prostatic cancer. Bone scintiscan is reliable. Its sensibility can be increased by using new radioactive isotopes and quantitative isotopic explorations. Bone marrow histologic study is indicated in case of a doubtful diagnosis, when there is a discordance between radiological and isotopic exploration.
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author | |
| pubmed:volume |
56
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
346-50
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:6246630-Biopsy,
pubmed-meshheading:6246630-Bone Marrow,
pubmed-meshheading:6246630-Bone and Bones,
pubmed-meshheading:6246630-Diagnosis, Differential,
pubmed-meshheading:6246630-Diphosphates,
pubmed-meshheading:6246630-Humans,
pubmed-meshheading:6246630-Male,
pubmed-meshheading:6246630-Prostatic Neoplasms,
pubmed-meshheading:6246630-Technetium
|
| pubmed:articleTitle |
[Recent advances in isotopic exploration of the skeletal system in prostate cancer (author's transl)].
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|